Back to Agenda
Session 8: How Will Our Experience Developing COVID Vaccines Change the Landscape of Vaccine Development?
Session Chair(s)
Nita Ichhpurani, PMP
Consultant To Daiichi Sankyo, Inc.
Phase One Forward, Consultant, Canada
COVID-19 vaccine development has propelled our industry to operate and collaborate in an unprecedented manner. What can we apply to future projects from Project Managers who have navigated in this global public health crisis? This session will focus on the lessons learnt, best practices and ways of working which can be taken forward as a result of the urgent planning and management required. We will discuss the successes, challenges and complications experienced which can inform future management of vaccine development.
Learning Objective : - Discuss best practices to utilize moving forward in vaccine development
- Identify PM tools and skills which were most useful to vaccine development
- Apply lessons learned to future vaccine projects
Speaker(s)
Speaker
Matt Lawlor, PhD, PMP
Novavax, Inc, United States
Executive Director and Interim Lead, Global Program Management
Speaker
Heather Lawlor, MSc, PMP
AstraZeneca, United States
Director, Global Portfolio and Project Management
Have an account?